newsfilter
← Latest News
Business Wire·

Acorda Therapeutics to Present INBRIJA® Data at the American Academy of Neurology Annual Meeting

Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that it will present data on INBRIJA (levodopa inhalation powder) and OFF Periods at the American Academy of Neurology (AAN) Annual Meeting, taking place in Boston